GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance

Radiotherapy and Oncology

Volumn 120, Issue 1, 2016, Pages 119-123

  Ott, Oliver J ^a   Strnad, Vratislav ^a   Hildebrandt, Guido ^b,c   Kauer Dorner, Daniela ^d   Knauerhase, Hellen ^c   Major, Tibor ^e   Łyczek, Jaroslaw ^f,g   Guinot, José Luis ^h   Dunst, Jürgen ⁱ   Miguelez, Cristina Gutierrez ^j   Slampa, Pavel ^k   Allgäuer, Michael ^m   Lössl, Kristina ^l   Polat, Bülent ^p   Kovács, György ⁿ   Fischedick, Arnt René ^o   Wendt, Thomas G ^q   Fietkau, Rainer ^a,d   Kortmann, Rolf Dieter ^b   Resch, Alexandra ^e   Kulik, Anna ^f   Arribas, Leo ^h   Niehoff, Peter ^i,r   Guedea, Ferran ^j   Schlamann, Annika ^b   Pötter, Richard ^e   Gall, Christine ^s   Malzer, Martina ^s   Uter, Wolfgang ^s   Polgár, Csaba ^e   more..

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^f INSTITUTE OF ONCOLOGY   (Poland)

^g Podkarpacki Hospital Cancer Center Brzozow   (Poland)

^h Valencian Institute of Oncology   (Spain)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^k MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^l UNIVERSITY OF BERN   (Switzerland)

^m Department of Vascular Surgery   (Germany)

ⁿ Interdisciplinary Brachytherapy Unit   (Germany)

^o Department of Radiation Oncology ^*  (Germany)

^p UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^q JENA UNIVERSITY HOSPITAL   (Germany)

^r UNIVERSITY OF WITTEN HERDECKE   (Germany)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

more..

Author keywords

Accelerated partial breast irradiation; Breast cancer; Early toxicity; GEC ESTRO APBI trial; Multicatheter brachytherapy; Randomized trial

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST INJURY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEMATOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTALGIA; MASTITIS; MULTICENTER STUDY; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; ADULT; ADVERSE EFFECTS; AGED; BREAST; BREAST NEOPLASMS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; MIDDLE AGED; PROCEDURES; RADIATION RESPONSE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 84992160836     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2016.06.019     Document Type: Article

References (18)

1. [1] Barry, M., Ho, A., Morrow, M., The evolving role of partial breast irradiation in early-stage breast cancer. Ann Surg Oncol 20 (2013), 2534–2540.
2. [2] Polgar, C., Major, T., Fodor, J., Sulyok, Z., Somogyi, A., Lovey, K., et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94 (2010), 274–279.
3. [3] Shah, C., Antonucci, J.V., Wilkinson, J.B., Wallace, M., Ghilezan, M., Chen, P., et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol 100 (2011), 210–214.
4. [4] Livi, L., Meattini, I., Marrazzo, L., Simontacchi, G., Pallotta, S., Saieva, C., et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer, 2015.
5. [5] Polgar, C., Fodor, J., Major, T., Sulyok, Z., Kasler, M., Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108 (2013), 197–202.
6. [6] Strnad, V., Ott, O.J., Hildebrandt, G., Kauer-Dorner, D., Knauerhase, H., Major, T., et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet, 2015.
7. [7] Veronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C., et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14 (2013), 1269–1277.
8. [8] ICRU Report 58: Dose and volume specification for reporting interstitial therapy. Bethesda, Maryland, USA, 1997.
9. [9] Cox, J.D., Stetz, J., Pajak, T.F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995), 1341–1346.
10. [10] LENT SOMA tables. Radiother Oncol 35 (1995), 17–60.
11. [11] Lettmaier, S., Kreppner, S., Lotter, M., Walser, M., Ott, O.J., Fietkau, R., et al. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol 100 (2011), 189–194.
12. [12] Vaidya, J.S., Joseph, D.J., Tobias, J.S., Bulsara, M., Wenz, F., Saunders, C., et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376 (2010), 91–102.
13. [13] Vaidya, J.S., Wenz, F., Bulsara, M., Tobias, J.S., Joseph, D.J., Keshtgar, M., et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383 (2014), 603–613.
14. [14] Rodriguez, N., Sanz, X., Dengra, J., Foro, P., Membrive, I., Reig, A., et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 87 (2013), 1051–1057.
15. [15] Dodwell, D.J., Dyker, K., Brown, J., Hawkins, K., Cohen, D., Stead, M., et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17 (2005), 618–622.
16. [16] Olivotto, I.A., Whelan, T.J., Parpia, S., Kim, D.H., Berrang, T., Truong, P.T., et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31 (2013), 4038–4045.
17. [17] Ribeiro, G.G., Dunn, G., Swindell, R., Harris, M., Banerjee, S.S., Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol 2 (1990), 27–34.
18. [18] Ott, O.J., Hildebrandt, G., Potter, R., Hammer, J., Lotter, M., Resch, A., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 82 (2007), 281–286.